Medinet Co Company
%20.jpg)
Cancer immuno-cell therapy is an advanced medical practice.
Estimated Revenue:
$1M to $10M
Funding Status:
IPO
Industry:
Biotechnology, Health Care, Medical, Therapeutics
Investors Number:
1
Last Funding Date:
42276
Technology:
Regenerative Medicine
Founded Date:
1995-01-01
Investor Type:
For Profit
Headquarters:
Japan
Total Funding:
511490000
Last Funding Type:
Post-IPO Equity
Employee Number:
51-100